Mednax Inc Stock Book Value Per Share
| MD Stock | USD 8.81 0.11 1.23% |
Mednax Inc fundamentals help investors to digest information that contributes to Mednax's financial success or failures. It also enables traders to predict the movement of Mednax Stock. The fundamental analysis module provides a way to measure Mednax's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mednax stock.
| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 10.11 | 9.67 | |
| Tangible Book Value Per Share | (6.62) | (6.95) |
Mednax | Book Value Per Share |
Mednax Inc Company Book Value Per Share Analysis
Mednax's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Mednax Book Value Per Share | 10.27 X |
Most of Mednax's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mednax Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Mednax Book Value Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Mednax is extremely important. It helps to project a fair market value of Mednax Stock properly, considering its historical fundamentals such as Book Value Per Share. Since Mednax's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mednax's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mednax's interrelated accounts and indicators.
Click cells to compare fundamentals
Mednax Book Value Per Share Historical Pattern
Today, most investors in Mednax Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mednax's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's book value per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Mednax book value per share as a starting point in their analysis.
Mednax Book Value Per Share |
| Timeline |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
Mednax Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
In accordance with the recently published financial statements, the book value per share of Mednax Inc is about 10.272 times. This is 704.24% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The book value per share for all United States stocks is 99.47% higher than that of the company.
Mednax Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mednax's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mednax could also be used in its relative valuation, which is a method of valuing Mednax by comparing valuation metrics of similar companies.Mednax is currently under evaluation in book value per share category among related companies.
Mednax ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mednax's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mednax's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Mednax Fundamentals
| Return On Equity | -0.0694 | ||||
| Return On Asset | 0.0432 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 1.25 B | ||||
| Shares Outstanding | 84.03 M | ||||
| Shares Owned By Insiders | 1.37 % | ||||
| Shares Owned By Institutions | 98.63 % | ||||
| Number Of Shares Shorted | 4.12 M | ||||
| Price To Earning | 89.39 X | ||||
| Price To Book | 0.91 X | ||||
| Price To Sales | 0.39 X | ||||
| Revenue | 1.99 B | ||||
| Gross Profit | 467.03 M | ||||
| EBITDA | 196.08 M | ||||
| Net Income | (60.41 M) | ||||
| Cash And Equivalents | 9.82 M | ||||
| Cash Per Share | 1.29 X | ||||
| Total Debt | 701.65 M | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 1.39 X | ||||
| Book Value Per Share | 10.27 X | ||||
| Cash Flow From Operations | 137.32 M | ||||
| Short Ratio | 5.43 X | ||||
| Price To Earnings To Growth | 0.88 X | ||||
| Target Price | 9.07 | ||||
| Number Of Employees | 5.45 K | ||||
| Beta | 1.58 | ||||
| Market Capitalization | 740.27 M | ||||
| Total Asset | 2.22 B | ||||
| Retained Earnings | (149.47 M) | ||||
| Working Capital | 94.51 M | ||||
| Current Asset | 527.77 M | ||||
| Current Liabilities | 428.77 M | ||||
| Net Asset | 2.22 B |
About Mednax Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mednax Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mednax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mednax Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Mednax Piotroski F Score and Mednax Altman Z Score analysis. Note that the Mednax Inc information on this page should be used as a complementary analysis to other Mednax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Mednax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.31) | Revenue Per Share 24.265 | Quarterly Revenue Growth (0.03) | Return On Assets 0.0432 | Return On Equity (0.07) |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.